Multiple Pathways of CD28 Costimulation

CD28 共刺激的多种途径

基本信息

  • 批准号:
    7068576
  • 负责人:
  • 金额:
    $ 34.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-01 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is well established that costimulation through CD28 can have a dramatic effect on T cell activation, survival, tolerance, and differentiation. However, in spite of considerable interest and effort, it has been unclear whether these different functions of CD28 are all mediated simply through amplification of TCR signaling or through the induction of one or more distinct signaling pathways. We have recently found that CD28 can transduce two independent signaling pathways that result in the upregulation of IL-2 secretion. One pathway is dependent in the ability of CD28 to activate phosphatidylinositol 3-kinase (PI3K) and results in the specific recruitment of PKCtheta to the cSMAC region of the immunological synapse, nuclear translocation of NF-kappaB, and upregulation of IL-2 transcription. This pathway may be mediated through proximal signal integration between TCR and CD28 signaling within the context of specific localization of proteins within the immunological synapse. The second pathway functions in the absence of CD28-mediated activation of PI3K and does not induce recruitment of PKCtheta to the immunological synapse or upregulation of IL-2 transcription. Nevertheless, costimulation through CD28 that cannot activate PI3K still induces normal levels of IL-2 secretion primarily through stabilization of IL-2 mRNA. This pathway also appears to function when CD28 costimulation is provided in trans and so may be mediated by signal integration downstream from the plasma membrane. The overall goal of this proposal is to define the cell biological, biochemical, and molecular steps that mediate these two independent pathways of CD28 costimulation. We will accomplish these goals through two specific aims: 1. Determine how targeting of CD28 and associated signaling molecules to the cSMAC impacts on CD28 costimulation of IL-2 transcription. 2. Identify the components of the PI3-kinase-independent CD28 signaling pathway that lead to IL-2 mRNA stabilization.
描述(由申请人提供):已经确定,通过CD 28的共刺激可以对T细胞活化、存活、耐受和分化产生显著影响。然而,尽管有相当大的兴趣和努力,但尚不清楚CD 28的这些不同功能是否都是简单地通过TCR信号传导的扩增或通过诱导一种或多种不同的信号传导途径介导的。我们最近发现,CD 28可以通过两条独立的信号通路上调IL-2的分泌。一种途径依赖于CD 28激活磷脂酰肌醇3-激酶(PI 3 K)的能力,并导致PKC θ特异性募集至免疫突触的cSMAC区域、NF-κ B核转位和IL-2转录上调。该途径可以通过在免疫突触内蛋白质的特异性定位的背景下TCR和CD 28信号传导之间的近端信号整合来介导。第二途径在不存在CD 28介导的PI 3 K活化的情况下起作用,并且不诱导PKC θ向免疫突触的募集或IL-2转录的上调。然而,通过不能激活PI 3 K的CD 28的共刺激仍然主要通过稳定IL-2 mRNA诱导正常水平的IL-2分泌。当以反式提供CD 28共刺激时,该途径似乎也起作用,因此可能由质膜下游的信号整合介导。该提案的总体目标是确定介导这两个独立的CD 28共刺激途径的细胞生物学、生物化学和分子步骤。 我们将通过两个具体目标实现这些目标: 1.确定CD 28和相关信号分子靶向cSMAC如何影响IL-2转录的CD 28共刺激。 2.鉴定导致IL-2 mRNA稳定的PI 3激酶非依赖性CD 28信号通路的组分。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JIM F Miller其他文献

JIM F Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JIM F Miller', 18)}}的其他基金

Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
  • 批准号:
    10241367
  • 财政年份:
    2014
  • 资助金额:
    $ 34.28万
  • 项目类别:
Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
  • 批准号:
    10477319
  • 财政年份:
    2014
  • 资助金额:
    $ 34.28万
  • 项目类别:
Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
  • 批准号:
    10689177
  • 财政年份:
    2014
  • 资助金额:
    $ 34.28万
  • 项目类别:
Tissue regulation of T cell function - Reagents Core
T 细胞功能的组织调节 - 试剂核心
  • 批准号:
    10002193
  • 财政年份:
    2014
  • 资助金额:
    $ 34.28万
  • 项目类别:
Targeting CD28 ligand binding
靶向 CD28 配体结合
  • 批准号:
    8649027
  • 财政年份:
    2013
  • 资助金额:
    $ 34.28万
  • 项目类别:
Targeting CD28 ligand binding
靶向 CD28 配体结合
  • 批准号:
    8489883
  • 财政年份:
    2013
  • 资助金额:
    $ 34.28万
  • 项目类别:
Translational control of GATA-3
GATA-3 的翻译控制
  • 批准号:
    8416331
  • 财政年份:
    2012
  • 资助金额:
    $ 34.28万
  • 项目类别:
Translational control of GATA-3
GATA-3 的翻译控制
  • 批准号:
    8301843
  • 财政年份:
    2012
  • 资助金额:
    $ 34.28万
  • 项目类别:
CD28 Triggering
CD28触发
  • 批准号:
    8089277
  • 财政年份:
    2010
  • 资助金额:
    $ 34.28万
  • 项目类别:
CD28 Triggering
CD28触发
  • 批准号:
    7963606
  • 财政年份:
    2010
  • 资助金额:
    $ 34.28万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 34.28万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 34.28万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 34.28万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 34.28万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 34.28万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 34.28万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 34.28万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 34.28万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 34.28万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 34.28万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了